北美解剖病理学市场预测至 2028 年 - 按产品和服务（仪器、消耗品和服务）、应用（疾病诊断、药物发现和开发等）和最终用户（医院、研究）划分的 COVID-19 影响和区域分析实验室、诊断实验室等）
市场介绍
解剖病理学是研究和治疗的重要组成部分疾病。解剖病理学是一个广泛的领域，包括尸体病理学、外科病理学、细胞病理学、神经病理学和眼科病理学。解剖病理学通常在医院的医学实验室和诊断实验室进行。
< span>市场概况和动态
北美解剖病理学市场预计到 2028 年将从 139.7095 亿美元增至 139.7095 亿美元2021年887041万；预计 2021 年至 2028 年复合年增长率为 6.7%。市场的增长归因于关键驱动因素，例如癌症和其他疾病患病率的增加以及对个性化的日益关注药物。然而，缺乏熟练的专业人员和严格的政府法规的实施阻碍了市场的增长。
癌症具有重大影响关于世界各地的社会。癌症对全球医疗保健系统的负担正在显着增加，因为它是导致死亡的主要原因之一。据美国国家癌症研究所称，2018年，全球新增病例1810万，死亡人数950万人。 30-69 岁成年人因非传染性疾病过早死亡的约 30% 是由癌症引起的。肺癌是世界上最常诊断的癌症。由于超重、肥胖和不健康饮食的增加，糖尿病的患病率正在增加，特别是在世界中等收入国家。超重和肥胖是导致 2 型糖尿病的主要危险因素之一。根据 IDF 糖尿病图谱第九版，2019 年，年龄在 20 至 79 岁之间的约 4.63 亿成年人患有糖尿病；而这个数字将上升到7亿。由于癌症和其他疾病的日益流行，政府机构、医疗保健提供者和机构被迫为疾病诊断和治疗举措做出贡献。因此，癌症和其他目标疾病患病率的激增正在推动北美解剖病理学市场的增长。个性化药物用于治疗乳腺癌和心血管疾病等疾病。与其他类型的治疗相比，个性化抗癌药物表现出更少且更不严重的副作用，因为它们是针对特定作用而设计的。此外，随着研究和临床研究的不断进展，个性化药物可能在提高患者护理质量方面发挥巨大潜力。因此，对个性化药物的日益关注正在推动解剖病理学市场的增长。
COVID-19 大流行和医疗保健资源的重新调整已经影响了诊断行业的各个方面，包括解剖病理学市场。关闭诊所、手术室和医生办公室，并“呆在家里”。北美各地的强制要求严重影响了病理学评估标本的获取和提交。过去两年，尽管医院提供急诊和 OPD 服务，但到医院就诊的患者数量却大幅减少。此外，由于大多数医院投入精力和资源来诊断和治疗 COVID-19，许多计划的手术被取消或推迟。结果，各种早期癌症检测系统被停用，所有尸检都被暂停。据世界经济论坛统计，全球有 2800 万例择期手术和 38% 的癌症手术被推迟。因此，解剖病理学实验室收到的外科病理学和细胞学样本的数量显着减少。结果，诊断测试的数量减少了。这一减少进一步减少了2020年第二季度解剖病理学产品的销量。此外，由于COVID-19患者的强劲增加，病理实验室现在优先考虑并专注于COVID-19测试。美国和加拿大感染患者数量的快速增加可能会阻碍未来北美解剖病理学市场的增长。目前，许多国家正在放松封锁限制，大多数医院已经恢复了择期手术。因此，诊断测试的数量现在正在增加。然而，由于COVID-19大流行的影响，解剖病理学市场的整体增长率低于上年。
主要细分市场
根据产品和服务，北美解剖病理学市场分为仪器、耗材和服务。 2021 年，服务细分市场占据最大市场份额，而仪器细分市场预计在预测期内的市场复合年增长率最高。
按应用划分，北美解剖病理学市场分为疾病诊断、药物发现和开发等。疾病诊断细分市场在 2021 年占据最大的市场份额。然而，药物发现和开发细分市场预计在 2021 年至 2028 年期间将实现最高的市场复合年增长率。
北美解剖病理学市场根据最终用户分为医院、研究实验室、诊断实验室等。其他部分包括制药和生物技术公司以及合同研究组织（CRO）。 2021 年，医院细分市场占据最大市场份额，预计诊断实验室细分市场在预测期内的复合年增长率最高。
主要来源和上市公司
一些主要和次要来源 在准备北美解剖病理学市场报告时提到了疾病控制和预防中心 (CDC)、食品和药物管理局 (FDA) 以及美国病理学家学会 (CAP)。
购买报告的理由
- 根据北美解剖病理学市场的详细趋势分析确定潜在投资领域 span>未来几年。
- 深入了解推动不同需求的潜在因素< span>成瘾治疗支出最高的国家的细分市场，并确定每个国家提供的机会。
- 加强您对成瘾治疗的了解市场需求驱动因素、行业趋势和最新技术发展等。
- 确定推动北方发展的主要渠道美国解剖病理学市场，提供了未来机会的清晰图景，有助于分析，从而实现收入扩张。
- 通过重点关注不同国家/地区正在进行的项目来引导资源 北美解剖病理学市场。
北美解剖病理学市场细分
作者产品和服务
- 服务
- 消耗品
- 仪器
按应用
- 疾病诊断
- 药物发现与开发
- 其他
最终用户
- 医院
- 研究实验室
- 诊断实验室
- 其他
按国家/地区
- 美国
- 加拿大
- 墨西哥
公司简介
- F.霍夫曼拉罗氏有限公司
- 丹纳赫
- Hologic, Inc.
- 安捷伦科技公司
- BioGenex
- Diapath SpA
- Bio SB
- MERCK KGaA
- BD
- PHC控股公司
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Anatomic Pathology Market – By Product and Services
1.3.2 North America Anatomic Pathology Market – By Application
1.3.3 North America Anatomic Pathology Market – By End User
1.3.4 North America Anatomic Pathology Market – By Country
2. Anatomic Pathology Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Anatomic Pathology Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.3 Expert Opinions
5. Anatomic Pathology Market — Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increase in Prevalence of Cancer and Other Diseases
5.1.2 Growing Focus on Personalized Medicines
5.2 Key Market Restraints
5.2.1 Lack of Skilled Professionals
5.2.2 Stringency of Government Regulations
5.3 Key Market Opportunities
5.3.1 Rise in Number of Clinical Trials for Anticancer Drugs
5.4 Future Trends
5.4.1 Development of New Technologies and Launch of Products
5.5 Impact Analysis
6. Anatomic Pathology Market – North America Analysis
6.1 North America Anatomic Pathology Market Revenue Forecast and Analysis
7. Anatomic Pathology Market Analysis – By Product and Service
7.1 Overview
7.2 Anatomic Pathology Market, by Product and Service (2020 and 2028)
7.3 Instruments
7.3.1 Overview
7.3.2 Instruments: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Consumables
7.4.1 Overview
7.4.2 Consumables: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Services
7.5.1 Overview
7.5.2 Services: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
8. Anatomic Pathology Market Analysis – By Application
8.1 Overview
8.2 Anatomic Pathology Market, by Application (2020 and 2028)
8.3 Disease Diagnosis
8.3.1 Overview
8.3.2 Disease Diagnosis: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Drug Discovery and Development
8.4.1 Overview
8.4.2 Drug Discovery and Development: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
9. Anatomic Pathology Market Analysis – By End User
9.1 Overview
9.2 Anatomic Pathology Market, by End User (2020 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Research Laboratories
9.4.1 Overview
9.4.2 Research Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Diagnostic Laboratories
9.5.1 Overview
9.5.2 Diagnostic Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
10. Anatomic Pathology Market – North America Analysis
10.1 North America: Anatomic Pathology Market
10.1.1 Overview
10.1.2 North America: Anatomic Pathology Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 US: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2 US Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3 US Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.4 US Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.2 Canada: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Canada: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Canada Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3 Canada Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.4 Canada Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.3 Mexico: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Mexico: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 Mexico Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3 Mexico Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.4 Mexico Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
11. Impact of COVID-19 Pandemic on Anatomic Pathology Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Anatomic Pathology Market– Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 F. HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Danaher
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Hologic, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Agilent Technologies, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 BioGenex
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Diapath S.p.A.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Bio SB
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 MERCK KGaA
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 BD
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 PHC Holdings Corporation
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. US Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 2. US Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 3. US Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 4. Canada Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 5. Canada Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 6. Canada Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. Mexico Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 8. Mexico Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 9. Mexico Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 10. Organic Developments Done by Companies
Table 11. Inorganic Developments Done by Companies
Table 12. Glossary of Terms, Anatomic Pathology Market
LIST OF FIGURES
Figure 1. Anatomic Pathology Market Segmentation
Figure 2. Anatomic Pathology Market Segmentation, By Country
Figure 3. Anatomic Pathology Market Overview
Figure 4. Services Segment Held Largest Share of Anatomic Pathology Market
Figure 5. North America Anatomic Pathology Market – Leading Country Markets (US$ Million)
Figure 6. North America PEST Analysis
Figure 7. Global Anatomic Pathology Market Impact Analysis of Drivers and Restraints
Figure 8. North America Anatomic Pathology Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Anatomic Pathology Market Revenue Share, by Product and Service (2020 and 2028)
Figure 10. Instruments: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Consumables: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Services: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Anatomic Pathology Market Revenue Share, by Application (2020 and 2028)
Figure 14. Disease Diagnosis: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Drug Discovery and Development: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Others: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Anatomic Pathology Market Revenue Share, by End User (2020 and 2028)
Figure 18. Hospitals: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Research Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Diagnostic Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America: Anatomic Pathology Market, by Key Country – Revenue (2021) (USD Million)
Figure 23. North America: Anatomic Pathology Market, by Country, 2021 & 2028 (%)
Figure 24. US: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. Canada: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. Mexico: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. Impact of COVID-19 Pandemic in North American Country Markets
- F. HOFFMANN-LA ROCHE LTD.
- Danaher
- Hologic, Inc.
- Agilent Technologies, Inc.
- BioGenex
- Diapath S.p.A.
- Bio SB
- MERCK KGaA
- BD
- PHC Holdings Corporation
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America anatomic pathology market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America anatomic pathology market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.